Skip to main content

Month: September 2020

UPDATE — Alimera Sciences Announces Participation at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference on September 15, 2020

ATLANTA, Sept. 09, 2020 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the development and commercialization of prescription ophthalmic pharmaceuticals, today announces that Rick Eiswirth, President and Chief Executive Officer, will present a corporate overview at the H. C. Wainwright and Company 22nd Annual Global Virtual Investor Conference on Tuesday September 15, 2020 at 3:30 PM ET. To listen to the conference live, please sign up at https://wsw.com/webcast/hcw7/alim/1592203.An archived presentation will be available from September 16th on the Alimera website at https://investors.alimerasciences.com/alim/corporate_documents?type=100510&template=most_recent_redirectIn addition, Mr. Eiswirth is available for virtual one-on-one meetings from September 14 – 16,...

Continue reading

iTeos participera aux prochaines conférences des investisseurs en septembre

CAMBRIDGE, Massachusetts et GOSSELIES, Belgique, 09 sept. 2020 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (Nasdaq : ITOS), une société biopharmaceutique au stade clinique pionnière dans la découverte et le développement d’une nouvelle génération de traitements d’immuno-oncologie hautement différenciés pour les patients, a annoncé aujourd’hui que sa direction participera aux deux prochaines conférences virtuelles des investisseurs en septembre.15e conférence virtuelle annuelle de Citi sur le secteur biopharmaceutiqueDate : Mercredi 9 septembre – Jeudi 10 septembre 202022e conférence mondiale annuelle de H.C. Wainwright sur l’investissementDate : Mardi 15 septembre 2020Heure de la présentation : 17h00 HNEUne webdiffusion audio en direct de la présentation de H.C. Wainwright sera disponible dans la section...

Continue reading

iTeos nimmt im September an bevorstehenden Anlegerkonferenzen teil

CAMBRIDGE, Massachusetts und GOSSELIES, Sept. 09, 2020 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (Nasdaq: ITOS), ein im klinischen Stadium tätiges biopharmazeutisches Unternehmen, das Pionierarbeit bei der Entdeckung und Entwicklung einer neuen Generation hoch differenzierter immunonkologischer Therapeutika für Patienten leistet, hat heute bekanntgegeben, dass die Geschäftsführung im September an zwei bevorstehenden virtuellen Anlegerkonferenzen teilnimmt.Citi’s 15th Annual BioPharma Virtual ConferenceDatum: Mittwoch, 9. September – Donnerstag, 10. September 2020H.C. Wainwright 22nd Annual Global Investment ConferenceDatum: Dienstag, 15. September 2020Zeit der Präsentation: 17:00 Uhr ETEin Live-Audio-Webcast der Präsentation bei H.C. Wainwright wird im Bereich Nachrichten und Veranstaltungen auf der Website für Anleger von...

Continue reading

MiX Telematics and Heavy Duty Trucking To Host Sept 17 Webinar: Video Telematics is Revolutionizing Driver Safety: Here’s How

BOCA RATON, Fla., Sept. 09, 2020 (GLOBE NEWSWIRE) — MiX Telematics (JSE: MIX, NYSE: MIXT) a leading global provider of fleet and mobile asset management solutions delivered as Software as a Service (SaaS), is proud to announce that it will present a webinar titled, “Video Telematics is Revolutionizing Driver Safety: Here’s How.”The event will take place Thu, Sep 17, 2020 11:00 AM PDT (2:00 PM EDT).Driver safety is a top priority for every fleet. New advances in video telematics are transforming the way fleets monitor and improve driver safety in a number of ways. Fleets are using video clips triggered by incidents and also live in-cab video to gain a better understanding of circumstances surrounding incidents, as well as overall driver behavior. These video resources can then be used to:Prevent incidents from occurringTrain drivers...

Continue reading

Update: Syneos Health to Present at the Baird 2020 Global Healthcare Conference at 12:15 p.m. ET Today

MORRISVILLE, N.C., Sept. 09, 2020 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced that the Company’s presentation at the Baird 2020 Global Healthcare Conference has been rescheduled because of technical issues. Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs will now present today at 12:15 p.m. ET. A live webcast of the event, along with a link to the presentation materials and archived audio replay of the presentation, will be available on the Company’s Investor Relations website at investor.syneoshealth.com.About Syneos HealthSyneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization....

Continue reading

Transcontinental inc. annonce ses résultats du troisième trimestre de l’exercice financier 2020

Faits saillantsAmélioration significative de la profitabilité du secteur de l’emballage et contrôle des coûts rigoureux dans le secteur de l’impression.Renforcement de nos mesures afin de protéger la santé et la sécurité de nos employés face à la pandémie et poursuite de nos programmes de soutien financier pour nos employés mis à pied temporairement ou en horaire réduit.Revenus de 587,4 millions $; résultat opérationnel de 75,3 millions $; et résultat net attribuable aux actionnaires de la Société de 48,3 millions $ (0,56 $ par action).Résultat opérationnel avant amortissement ajusté(1) de 139,3 millions $; résultat opérationnel ajusté(1) de 102,1 millions $; et résultat net attribuable aux actionnaires de la Société ajusté(1) de 68,2 millions $ (0,78 $ par action).Solide santé financière avec une amélioration du ratio d’endettement...

Continue reading

Transcontinental Inc. announces its results for the third quarter of fiscal 2020

HighlightsSignificantly improved profitability in the Packaging Sector and strictly controlled costs in the Printing Sector.Strengthened our measures to protect employee health and safety during the pandemic and maintained our financial support programs for employees who were temporarily laid off or on reduced work schedules.Revenues of $587.4 million; operating earnings of $75.3 million; and net earnings attributable to shareholders of the Corporation of $48.3 million ($0.56 per share).Adjusted operating earnings before depreciation and amortization(1) of $139.3 million; adjusted operating earnings(1) of $102.1 million; and adjusted net earnings attributable to shareholders of the Corporation(1) of $68.2 million ($0.78 per share).Maintained solid financial health with an improved net indebtedness ratio(1) of 2.0x (1.8x excluding the...

Continue reading

Canoe EIT Income Fund Announces September 2020 Distribution

CALGARY, Alberta, Sept. 09, 2020 (GLOBE NEWSWIRE) — Canoe EIT Income Fund (the “Fund”) (TSX – EIT.UN) announces the September 2020 distribution of $0.10 per unit.  The distribution will be paid on October 15, 2020 to unitholders of record on September 22, 2020.  The ex-distribution date for this distribution is September 21, 2020.About Canoe EIT Income FundOne of Canada’s largest closed-end investment funds, designed to maximize monthly distributions and capital appreciation by investing in a broadly diversified portfolio of high quality securities. The Fund is listed on the TSX under the symbol EIT.UN and is actively managed by Robert Taylor, Senior Vice President and Portfolio Manager of Canoe Financial.About Canoe FinancialCanoe Financial is one of Canada’s fastest growing independent mutual fund companies managing over...

Continue reading

Independence Holding Company Announces the Collection of an Arbitration Award

STAMFORD, Conn., Sept. 09, 2020 (GLOBE NEWSWIRE) — Independence Holding Company (NYSE: IHC) today reported that it has now collected in excess of $5.6 million on the previously announced arbitration award proceeding against a third party administrator with which we formerly did business. IHC will record this award and include it in its third quarter earnings.About The IHC GroupIndependence Holding Company (NYSE: IHC), formed in 1980, is a holding company that is principally engaged in underwriting, administering and/or distributing group and individual specialty benefit products, including disability, supplemental health, pet, and group life insurance through its subsidiaries (Independence Holding Company and its subsidiaries collectively referred to as “The IHC Group”).  The IHC Group consists of three insurance companies (Standard...

Continue reading

Freddie Mac Multifamily Adds to Impact Lineup with First Social Bonds Offering

MCLEAN, Va., Sept. 09, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) Multifamily is adding to its lineup of Impact Bonds Offerings, today announcing it has gone to market with its first structured Social Bonds deal. According to the company’s Social Bonds Framework, the proceeds of Freddie Mac’s Social Bonds are used either to provide liquidity to social impact financial institutions for financing of affordable housing or to finance multifamily properties originated by the Freddie Mac Multifamily Optigo® network that are affordable to an underserved population.“We’re proud to have brought our first Social Bonds offering to market, which is yet another addition to our Impact lineup,” said Robert Koontz, senior vice president of Capital Markets for Freddie Mac Multifamily. “Last year we launched our K-G series to support our workforce...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.